Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Weber

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|April 20, 2004
Can HIV-1 superinfection compromise antiretroviral therapy?Bikram Chakraborty, Patti Kiser, Hector R Rangel, et al.
Journal of Virology|September 20, 2002
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutationMiguel E Quiñones-Mateu, Mahlet Tadele, Mariona Parera, et al.
Nature Communications|January 20, 2024
Ramping dynamics and theta oscillations reflect dissociable signatures during rule-guided human behaviorJan Weber, Anne-Kristin Solbakk, Alejandro O Blenkmann, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitorsVáclav Zima, Kateřina Radilová, Milan Kožíšek, et al.
Frontiers in Bioengineering and Biotechnology|March 3, 2022
Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal PlasmaKlára Obrová, Eva Vaňková, Michal Sláma, et al.
Frontiers in Immunology|March 15, 2018
The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic CellsVaclav Janovec, Besma Aouar, Albert Font-Haro, et al.
AIDS Research and Therapy|March 24, 2017
Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individualsJan Weber, Richard M Gibson, Lenka Sácká, et al.
Scientific Reports|July 31, 2020
Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytesVaclav Janovec, Jan Hodek, Kamila Clarova, et al.
Scientific Reports|January 22, 2025
Synthesis, H<sub>2</sub>S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5'-dithioacetatesMiklós Bege, Miklós Lovas, Dániel Priksz, et al.
ACS Infectious Diseases|January 4, 2021
Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA VirusesNemanja Milisavljevic, Eva Konkolová, Jaroslav Kozák, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|April 20, 2004
Can HIV-1 superinfection compromise antiretroviral therapy?Bikram Chakraborty, Patti Kiser, Hector R Rangel, et al.
Journal of Virology|September 20, 2002
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutationMiguel E Quiñones-Mateu, Mahlet Tadele, Mariona Parera, et al.
Nature Communications|January 20, 2024
Ramping dynamics and theta oscillations reflect dissociable signatures during rule-guided human behaviorJan Weber, Anne-Kristin Solbakk, Alejandro O Blenkmann, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitorsVáclav Zima, Kateřina Radilová, Milan Kožíšek, et al.
Frontiers in Bioengineering and Biotechnology|March 3, 2022
Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal PlasmaKlára Obrová, Eva Vaňková, Michal Sláma, et al.
Frontiers in Immunology|March 15, 2018
The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic CellsVaclav Janovec, Besma Aouar, Albert Font-Haro, et al.
AIDS Research and Therapy|March 24, 2017
Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individualsJan Weber, Richard M Gibson, Lenka Sácká, et al.
Scientific Reports|July 31, 2020
Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytesVaclav Janovec, Jan Hodek, Kamila Clarova, et al.
Scientific Reports|January 22, 2025
Synthesis, H<sub>2</sub>S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5'-dithioacetatesMiklós Bege, Miklós Lovas, Dániel Priksz, et al.
ACS Infectious Diseases|January 4, 2021
Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA VirusesNemanja Milisavljevic, Eva Konkolová, Jaroslav Kozák, et al.
Pageof 14